STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world's first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announced its half-year results for the six months ending 30 June 2013, approved by the Board at its meeting on 28 August 2013.
Help employers find you! Check out all the jobs and post your resume.
